Literature DB >> 8510225

Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor.

A Budkowska1, C Quan, F Groh, P Bedossa, P Dubreuil, J P Bouvet, J Pillot.   

Abstract

A hepatitis B virus (HBV) binding factor (HBV-BF) was identified in normal human serum interacting with the pre-S1 and pre-S2 epitopes of the viral envelope located within the protein domains involved in recognition of hepatocyte receptor(s). This molecule was characterized as a 50-kDa glycoprotein showing an isoelectric point of 7.13 with a biological activity depending on its native molecular conformation and on intact sulfhydryl bonds. Monoclonal antibodies to HBV-BF recognized a membrane component of the normal human liver whereas they were unreactive with hepatocyte membranes of other species and with those of the HepG2 cell line. These results suggest that the HBV-BF represents a soluble fragment of the membrane component and can be related to the HBV receptor mediating attachment of HBV to human liver cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510225      PMCID: PMC237802          DOI: 10.1128/JVI.67.7.4316-4322.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Significance of extrahepatic replication of hepatitis B virus.

Authors:  M Omata
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

2.  Growth hormone receptor and serum binding protein: purification, cloning and expression.

Authors:  D W Leung; S A Spencer; G Cachianes; R G Hammonds; C Collins; W J Henzel; R Barnard; M J Waters; W I Wood
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

3.  Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles.

Authors:  P Pontisso; M G Ruvoletto; W H Gerlich; K H Heermann; R Bardini; A Alberti
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

4.  Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.

Authors:  A R Neurath; B Seto; N Strick
Journal:  Vaccine       Date:  1989-06       Impact factor: 3.641

5.  Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.

Authors:  L T Mimms; M Floreani; J Tyner; E Whitters; R Rosenlof; L Wray; A Goetze; V Sarin; K Eble
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

6.  Detection of receptors for hepatitis B virus on cells of extrahepatic origin.

Authors:  A R Neurath; N Strick; P Sproul; H E Ralph; J Valinsky
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

7.  A soluble form of CD4 (T4) protein inhibits AIDS virus infection.

Authors:  K C Deen; J S McDougal; R Inacker; G Folena-Wasserman; J Arthos; J Rosenberg; P J Maddon; R Axel; R W Sweet
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

8.  Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region.

Authors:  P Pontisso; M A Petit; M J Bankowski; M E Peeples
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection.

Authors:  S D Marlin; D E Staunton; T A Springer; C Stratowa; W Sommergruber; V J Merluzzi
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

10.  Soluble cytokine receptors are present in normal human urine.

Authors:  D Novick; H Engelmann; D Wallach; M Rubinstein
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  12 in total

1.  An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus.

Authors:  C J Ryu; D Y Cho; P Gripon; H S Kim; C Guguen-Guillouzo; H J Hong
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Authors:  Qiang Deng; Jian-wei Zhai; Marie-Louise Michel; Jun Zhang; Jun Qin; Yu-ying Kong; Xin-xin Zhang; Agata Budkowska; Pierre Tiollais; Yuan Wang; You-hua Xie
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

Review 4.  Deciphering the mystery of hepatitis B virus receptors: A historical perspective.

Authors:  Zaira Rehman; Ammad Fahim; Hajra Sadia
Journal:  Virusdisease       Date:  2015-07-03

5.  Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus.

Authors:  M R Dyson; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

6.  Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection.

Authors:  S Tong; J Li; J R Wands
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity.

Authors:  J Le Seyec; P Chouteau; I Cannie; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.

Authors:  X Lu; T M Block; W H Gerlich
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain.

Authors:  A Budkowska; P Bedossa; F Groh; A Louise; J Pillot
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Hepatitis B virus surface antigen binds to apolipoprotein H.

Authors:  H Mehdi; M J Kaplan; F Y Anlar; X Yang; R Bayer; K Sutherland; M E Peeples
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.